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Abstract
Autophagy is a universally conserved metabolic program of catabolism that plays important roles in
energy homeostasis and impacts both normal physiology and multiple disease processes, including
cancer. Autophagy has been documented as a pro-survival mechanism used to maintain viability under
starvation conditions; however, conflicting findings have also implicated autophagy in the control of
cell death. Adding to the controversy, central mediators of autophagy have been implicated in both
pro-survival and pro-death processes. This report highlights recent insights into our understanding of
how autophagy is regulated and newly discovered physiological roles for autophagy in normal biology
and disease.
Introduction and context
Cellular systems maintain homeostatic equilibrium
through a constant balance between biosynthetic (ana-
bolic) processes and catabolism. Macroautophagy,
herein referred to as autophagy, is an evolutionarily
conserved, catabolic metabolic program that is a key
pathway for cellular adaptation to metabolic stresses
such as nutrient withdrawal (amino acids and glucose)
or hypoxia. During autophagy, internal cellular compo-
nents, including bulk cytoplasm and organelles, are
sequestered into double-membrane structures known as
autophagic vesicles (AVs). Following fusion of AVs to
lysosomes, the internal contents are degraded, and the
degradation products are used to fuel catabolic meta-
bolic processes for energy generation [1]. Starvation-
induced autophagy is an important process by which
cells ‘recycle’ existing contents for fuel to promote cell
viability, while basal levels of autophagy play a critical
role in protein and organelle quality control [2].
Autophagy is induced through a stepwise process
culminating in the assembly of the autophagosome
by core autophagy machinery. A distinct family of
autophagy-related genes that mediate the assembly and
processing of the autophagosome have been identified
[3]. At the molecular level, the induction of autophagy is
linked to signal transduction pathways involved in
nutrient sensing (Figure 1). Signalling by the phospha-
tidylinositol 3
0-kinase (PI3K)/Akt/mammalian target of
rapamycin (mTOR) pathway downstream of growth
receptors engages cellular programs of growth and
proliferation and inhibits catabolic metabolic pathways,
including autophagy [4]. Inhibition of mTOR, which
integrates growth factor signals and amino acid avail-
ability to regulate cap-dependent protein translation, is
associated with the induction of autophagy [5]. Low
cellular energy levels can stimulate autophagy by
inhibiting mTOR, a process regulated in part by an
LKB1/AMPK (AMP-activated protein kinase)-mediated
energy checkpoint [6-8].
Major recent advances
Regulation by amino acids
Several recent breakthroughs have advanced our under-
standing of the molecular mechanisms governing the
regulation of autophagy. mTOR activity has long been
known to be responsive to nutrient levels; amino acid
depletion is a potent stimulator of autophagy. However,
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activation and autophagy inhibition have remained one
of the key outstanding questions in the field. Three
independent studies by the groups of Guan, Sabatini,
and Murphy have provided new mechanistic insight into
how nutrients direct autophagy. The first insight was the
identification of the Rag family of small GTPases as key
stimulators of mTOR complex 1 (mTORC1) activity in
response to amino acids [9,10]. Amino acids stimulate
the association of Rag GTPases with the mTOR-binding
partner Raptor, resulting in mTOR activation (Figure 1).
Constitutively active Rag mutants mimic a ‘nutrient
replete’ state, conferring resistance to starvation-induced
autophagy triggered by amino acid withdrawal. Second,
Nicklin et al. [11] provided evidence for a coupled
glutamine-leucine amino acid shuttle system involved in
mTOR regulation and autophagy induction. They
demonstrated that glutamine import by the glutamine
Figure 1. Pathways of autophagy control in mammalian cells
(A) Under normal growth conditions, signal transduction downstream of growth factor receptors activates mTORC1 via the PI3K/Akt pathway. Activation of
mTORC1 promotes cell growth through the regulation of cap-dependent protein translation and the simultaneous inhibition of autophagy. Glutamine (Gln) is
transported into cells via the SLC1A5 glutamine transporter and is subsequently used to import leucine (Leu) via the SLC7A5-SLC3A2 complex. Intracellular
leucine activates mTORC1 Rag GTPases or a second undefined pathway. Basal autophagy is maintained under these conditions by the activity of Beclin-1,
which is inhibited by anti-apoptotic Bcl-2 and Bcl-XL. Bcl-2 and Bcl-XL also function to maintain viability by antagonizing Bax/Bak-dependent mitochondrial
apoptosis. (B) Under conditions of metabolic stress, including nutrient depletion (glucose and amino acid), growth factor withdrawal, or energy deficit, the
mTOR pathway is inhibited, resulting in autophagy induction. Under conditions of glutamine depletion, the resulting decline in leucine import reduces amino
acid-dependent activation of mTORC1. Activation of the LKB1-AMPK pathway by energetic imbalance results in mTORC1 inhibition through activation of the
TSC1-TSC2 complex and inhibition of the mTOR-binding partner Raptor. Extended periods of nutrient withdrawal can induce mitochondrial-dependent
apoptosis through activation of caspases downstream of Bax/Bak-dependent cytochrome c (Cyt c) release. Antagonism of Bcl-2 family members by BH3-only
proteins may trigger either autophagy or apoptosis, depending on the context. AMPK, AMP-activated protein kinase; mito, mitochondrion; mTOR,
mammalian target of rapamycin; mTORC1, mTOR complex 1; PI3K, phosphatidylinositol 3
0-kinase; TSC, tuberous sclerosis protein.
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via the SLC7A5-SLC3A2 antiporter; intracellular leucine
is then sensed by intracellular mediators (possibly Rag
GTPases) to stimulate mTOR activity (Figure 1). Knock-
down of expression of either SLC1A5 or SLC7A5-SLC3A2
results in the induction of autophagy and a reduction in
cell size [11]. Thus, amino acid transporters upstream of
mTOR play a key role in autophagy regulation by
dictating amino acid availability.
Autophagy and cell death
Autophagy has been ascribed both cytoprotective and
pro-apoptotic functions, and as such the role of
autophagy in cell death has remained controversial.
‘Autophagic’ cell death is loosely defined by the presence
of autophagosomes in dying cells [12]. The use of this
classification is poor as autophagy, like apoptosis, is a
cellular morphology, and many, if not most, cells
increase their rate of autophagy under conditions of
stress that promote cell death. Thus, defining cell
death as ‘autophagic’ based on the presence of AVs
may not be accurate [13]. Confounding this classifica-
tion, autophagy can induce cell death directly through
both conventional apoptotic machinery [14] and
caspase-independent processes [15], depending on the
context. Moreover, when metabolic stress is induced in
cells lacking the function of conventional apoptotic
pathways, autophagy ultimately results in energetic
crisis, leading to necrosis [1]. Thus, under pathophysio-
logical conditions of nutrient or oxygen limitation (that
is, a growing tumour lacking vasculature), autophagy
may promote necrosis instead of apoptosis. It remains
unclear whether autophagic cell death functions as a
central mediator of programmed cell death or is simply a
mechanism of ‘last resort’ when conventional apoptosis
pathways are impaired.
Recent findings in lower organisms have suggested a
physiological role for autophagy in cell death control
during normal development. Autophagy is specifically
induced in Drosophila melanogaster at two develop-
mental stages – germarium and mid-oogenesis – and
induction of autophagy at these stages promotes
starvation-induced cell death [16,17]. Interestingly,
these developmental stages are highly influenced by
nutritional status, which may suggest that ‘autophagy as
executioner’ is primarily linked to cellular bioenergetics
rather than other apoptotic pathways such as those
triggered by DNA damage. To date, the demonstration
of a required role for autophagy in cell death control
during development in vivo has been limited to
experimental systems in the fruit fly. Whether auto-
phagy plays a similar role in mammals remains to be
determined.
While its role in cell death control remains unclear,
autophagy has been implicated in coordinating the
clearance of dying cells and cellular debris. The ‘recycling’
function of autophagy serves an important role in the
clearance of apoptotic cells [18]. Deregulation of
autophagy has been implicated in various pathological
conditions, including neurodegeneration [19] and
tumourigenesis (discussed in the following section).
The contribution of autophagic cell death to these
processes remains an open question.
Autophagy and tumour suppression
The involvement of autophagy in cancer development
and progression has been an important recent advance
in the field of cancer biology. The upregulation of
autophagy has been correlated with differing stages of
cancer progression. In particular, autophagy is believed
to be upregulated in cancerous lesions marked by
environments of decreased oxygen or nutrient stress or
both. Multiple lines of evidence suggest that oncogene
and tumour suppressor networks exert opposing effects
on autophagy. When activated, several oncogenes,
including PI3K/Akt, mTOR, and Bcl-2, function largely
as inhibitors of autophagy, while tumour suppressors
[that is, PTEN (phosphatase and tensin homologue),
Beclin-1, tuberous sclerosis protein 2 (TSC2), LKB1, and
p53] stimulate autophagy [20]. This dichotomy has
remained controversial though, as autophagy can
promote cell survival in response to cellular stress and
thus autophagy could potentially contribute to onco-
genesis. However, the involvement of autophagy in
tumour suppression may actually stem from its role in
the degradation of damaged proteins and organelles,
including mitochondria, rather than its role in stress
responses [18].
Beclin-1 remains the primary autophagy regulator
associated with tumourigenesis. Haploinsufficiency of
Beclin-1 promotes tumourigenesis in mouse models and
is associated with breast and ovarian tumours in humans
[21,22]. This may be due in part to a still poorly defined
role for Beclin-1 in the maintenance of chromosome
integrity [23]. Modifiers of Beclin-1 activity can alter
tumourigenic potential; positive regulators of Beclin-1,
including UVRAG (UV radiation-associated gene) and
Bif, display tumour suppressor properties [24,25], while
Beclin-1 function is inhibited by Bcl-2 [26], a known
oncogene. Together, these data suggest that regulation of
basal levels of autophagy through Beclin-1 is an
important gateway to tumourigenesis. Another regulator
of autophagy is the tumour suppressor p53, although its
role in autophagy induction remains controversial. The
ability of p53 to induce autophagy appears to depend on
its cellular localization; nuclear localized p53 triggers
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trol of autophagy mediators, including DRAM (damage-
regulated autophagy modulator) [27], while cytoplasmic
p53 appears to function as a negative regulator [28].
Growing tumours require p53-dependent autophagy to
survive metabolic stress in vivo [7] and may represent an
important avenue for therapeutic intervention, particu-
larly in p53-deficient tumours.
Future directions
Much insight has been gained into the mechanisms and
biology of autophagy, but many questions remain.
Although we have focussed solely on macroautophagy
in this report, autophagy exists in several distinct forms
(that is, microautophagy and chaperone-mediated
autophagy) and can target specific cellular organelles
(that is, pexophagy and mitophagy). Understanding the
differential regulation of these processes remains a
major challenge for the field. In addition, despite recent
advances, our knowledge of the signalling networks and
layers of regulation that govern autophagy is limited.
For example, what are the mechanisms by which amino
acids signal to Rag GTPases (or other mediators) to
limit autophagy? How do other non-metabolic stressors
such as DNA-damaging agents signal to the autophagy
machinery? Finally, recent studies have implicated
autophagy as an integral biological process involved
in a number of pathophysiological conditions, includ-
ing cancer, neurodegeneration, aging, and infectious
disease. The challenge will be to identify the exact role –
positive or negative – that autophagy plays in these
conditions, to determine the underlying mechanisms
that regulate autophagy in each case, and to translate
this knowledge into autophagy-based therapeutics to
treat disease.
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